History and molecular genetics of lynch syndrome in family G: A century later

JAMA

Volumn 294, Issue 17, 2005, Pages 2195-2202

  Douglas, Julie A ^a   Gruber, Stephen B ^a   Meister, Karen A ^a   Bonner, Joseph ^a   Watson, Patrice ^b   Krush, Anne J ^c   Lynch, Henry T ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MSH2;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BINDING SITE; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; ENDOMETRIUM CANCER; EXON; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENE MUTATION; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; PRIORITY JOURNAL; RECTUM CANCER; SEQUENCE HOMOLOGY;

EID: 27644482922     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.294.17.2195     Document Type: Article

References (31)

1. Warthin AS. Heredity with reference to carcinoma. Arch Intern Med. 1913;12:546-555.
2. Warthin AS. The further study of a cancer family. J Cancer Res. 1925;9:279-286.
3. Hauser IJ, Weller CV. A further report on the cancer family of Warthin. Am J Cancer. 1936;27:434-449.
4. Lynch HT, Krush AJ. Cancer family "G" revisited: 1895-1970. Cancer. 1971;27:1505-1511.
5. Lynch HT, de la Chapelle A. Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet. 1999;36:801-818.
6. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003;348:919-932.
7. Marra G, Boland CR. Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst. 1995;87:1114-1125.
8. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum. 1991;34:424-425.
9. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for Hereditary Nonpolyposis Colorectal Cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology. 1999;116:1453-1456.
10. Bronner CE, Baker SM, Morrison PT, et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature. 1994;368:258-261.
11. Papadopoulos N, Nicolaides NC, Wei YF, et al. Mutation of a mutL homolog in hereditary colon cancer. Science. 1994;263:1625-1629.
12. Fishel R, Lescoe MK, Rao MR, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 1993;75:1027-1038.
13. Leach FS, Nicolaides NC, Papadopoulos N, et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell. 1993;75:1215-1225.
14. Akiyama Y, Sato H, Yamada T, et al. Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. Cancer Res. 1997;57:3920-3923.
15. Miyaki M, Konishi M, Tanaka K, et al. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet. 1997;17:271-272.
16. Nicolaides NC, Papadopoulos N, Liu B, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature. 1994;371:75-80.
17. Yan H, Papadopoulos N, Marra G, et al. Conversion of diploidy to haploidy. Nature. 2000;403:723-724.
18. Gruber SB. Assay for detecting the I1307K susceptibility allele within the adenomatous polyposis gene. In: Killian AA, ed. Molecular Pathology Protocols. Towota, NJ: Humana Press; 2000:263-270.
19. Rothman KJ, Boice JDJ. Epidemiologic Analysis With a Programmable Calculator. Washington, DC: US Government Printing Office; 1979. Report 79-1649.
20. Heston JF, Kelly JB, Meigs JW, Flannery JT. Forty-five Years of Cancer Incidence in Connecticut: 1935-79. Bethesda, Md: National Institutes of Health 1986. NIH 86-2652.
21. Taeger D, Sun Y, Keil U, Straif K. A stand-alone Windows applications for computing exact person-years, standardized mortality ratios and confidence intervals in epidemiological studies. Epidemiology. 2000;11:607-608.
22. Itoh H, Houlston RS, Harocopos C, Slack J. Risk of cancer death in first-degree relatives of patients with hereditary non-polyposis cancer syndrome (Lynch type II): a study of 130 kindreds in the United Kingdom. Br J Surg. 1990;77:1367-1370.
23. Lynch HT, Smyrk TC, Watson P, et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology. 1993;104:1535-1549.
24. Scott RJ, McPhillips M, Meldrum CJ, et al. Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet. 2001;68:118-127.
25. Parc Y, Boisson C, Thomas G, Olschwang S. Cancer risk in 348 French MSH2 or MLH1 gene carriers. J Med Genet. 2003;40:208-213.
26. Salovaara R, Loukola A, Kristo P, et al. Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol. 2000;18:2193-2200.
27. Jarvinen HJ, Mecklin JP, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 1995;108:1405-1411.
28. Jarvinen HJ, Aarnio M, Mustonen H, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 2000;118:829-834.
29. Vasen HF, van Ballegooijen M, Buskens E, et al. A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers. Cancer. 1998;82:1632-1637.
30. Lerman C, Hughes C, Trock BJ, et al. Genetic testing in families with hereditary nonpolyposis colon cancer. JAMA. 1999;281:1618-1622.
31. Watson P, Narod SA, Fodde R, et al. Carrier risk status changes resulting from mutation testing in hereditary non-polyposis colorectal cancer and hereditary breast-ovarian cancer. J Med Genet. 2003;40:591-596.